Sweet and Low

Glucose activates sleep-promoting neurons in the mouse hypothalamus.

Written byAshley P. Taylor
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SUGAR COMA MODEL: An injection of glucose into the ventrolateral preoptic nucleus (VLPO) of the anterior hypothalamus fuels ATP production in sleep-promoting neurons located in the VLPO. This boost in cellular ATP closes potassium channels (KATP), leading to neuronal excitation and the onset of sleep. When the VLPO sleep-promoting neurons fire, they inhibit arousal-promoting areas of the brain (inset, orange; sleep-promoting areas in blue). Glucose can also reduce arousal by directly inhibiting orexin-releasing neurons.
See full infographic: WEB | PDF
© KIMBERLY BATTISTA. INSET REDRAWN WITH PERMISSION FROM THIERRY GALLOPIN

The paper
C. Varin et al., “Glucose induces slow-wave sleep by exciting the sleep-promoting neurons in the ventrolateral preoptic nucleus: A new link between sleep and metabolism,” J Neurosci, 35:9900-11, 2015.

That drowsy feeling after a big meal—the so-called food coma—may actually be the result of increased neuronal activity. New research in mice suggests that sugar excites neurons in a brain region, called the ventrolateral preoptic nucleus (VLPO) of the hypothalamus, that induces sleep.

“What [the researchers] show is that these ventrolateral preoptic neurons are glucose responsive, and they show that in times of high glucose, they fire more,” says Harvard University neuroscientist Clifford Saper, who was not involved with the study. “If you’ve ever had a big meal, and you get sleepy afterward...this may ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies